RE: Catalyst5 Aug 2021 10:22
Next thing will likely to be granting of OD status for Glioma which could happen in the next few weeks or so (application submitted 13/7), and after that IND application in Q4, followed by the commencement of the trial in early 2022.
Other 'out of the blue' news e.g. licencing deals could come at any time.